ICSASG

NEW YORK (GenomeWeb) — An international consortium announced today that it has sequenced the Atlantic salmon genome.

The RFP is "targeting large-scale sequencing centers or a consortium of academic and/or commercial centers that are believed to have the expertise and capacity to participate in a project of this scale."

Canada, Chile, and Norway are seeking a center to finish sequencing the Atlantic salmon genome.

Last year, the consortium, which involves researchers, funding agencies, and industry representatives from Canada, Chile, and Norway, awarded a $6 million contract to Beckman Coulter Genomics for the first phase of the project, which uses Sanger sequencing.

The ICSASG recommends Sanger sequencing or a technology of equivalent read length and quality, rather than one of the current next-generation sequencing technologies, for the first phase of the project. The second phase will likely involve novel sequencing technologies.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.